|
|
Exchange: |
N/A |
Security
Type: |
Common |
Shares
Out: |
173,970,000 |
Market
Cap: |
4.96(B) |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$13.29 - $43.89 |
|
Level
I Sector: |
N/A |
Level
II Sector: |
N/A |
Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile BridegeBio Pharma identifies and improves medicines to treat patients who suffer from Mendelian diseases, which are diseases that arise from defects in a single gene, and cancers with clear genetic drivers. Co.'s pipeline are: Acoramidis/AG10/BBP-265, a small molecule transthyretin (TTR) stabilizer for the treatment of TTR amyloidosis; Infigratinib/BBP-831, an oral FGFR1-3 selective tyrosine kinase inhibitor for the treatment of achondroplasia; BBP-631, a preclinical adeno-associated virus gene transfer for the treatment of congenital adrenal hyperplasia; and Encaleret, a small molecule antagonist of the calcium sensing receptor for the treatment of Autosomal Dominant Hypocalcemia Type 1.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
5,415 |
192,897 |
1,845,608 |
2,886,602 |
Total Sell Value |
$195,041 |
$7,018,061 |
$62,779,686 |
$73,415,196 |
Total People Sold |
2 |
5 |
6 |
6 |
Total Sell Transactions |
2 |
10 |
16 |
29 |
End Date |
2024-02-11 |
2023-11-10 |
2023-05-12 |
2022-05-12 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Saunders Brent L |
Director |
|
2021-12-29 |
4 |
B |
$14.48 |
$254,880 |
D/D |
17,600 |
17,600 |
2.39 |
-60% |
|
Lo Andrew |
Director |
|
2021-12-29 |
4 |
B |
$12.90 |
$77,400 |
D/D |
6,000 |
46,599 |
2.39 |
-60% |
|
Valantine Hannah |
Director |
|
2021-12-29 |
4 |
B |
$14.23 |
$25,102 |
D/D |
1,764 |
1,764 |
2.39 |
-60% |
|
Hassan Fred |
Director |
|
2021-12-29 |
4 |
B |
$14.17 |
$273,390 |
D/D |
19,300 |
19,300 |
2.39 |
-60% |
|
Momtazee James C |
Director |
|
2021-12-29 |
4 |
B |
$14.50 |
$1,160,000 |
D/D |
80,000 |
88,491 |
2.39 |
-60% |
|
Valantine Hannah |
|
|
2021-12-28 |
4 |
B |
$12.68 |
$44,476 |
I/I |
3,433 |
3,433 |
0.01 |
-50% |
|
Daniels Ronald J |
Director |
|
2021-12-28 |
4 |
S |
$12.80 |
$150,336 |
D/D |
(11,745) |
0 |
|
50% |
|
Daniels Ronald J |
Director |
|
2021-12-28 |
4 |
B |
$12.73 |
$149,514 |
D/D |
11,745 |
11,745 |
2.39 |
-50% |
|
Cook Jennifer E. |
Director |
|
2021-11-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,576 |
7,152 |
|
- |
|
Kumar Neil |
CEO and President |
|
2021-11-16 |
4 |
D |
$47.25 |
$176,243 |
D/D |
(3,730) |
4,722,804 |
|
- |
|
Kumar Neil |
CEO and President |
|
2021-11-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
7,523 |
4,726,534 |
|
- |
|
Stephenson Brian C |
See Remarks |
|
2021-11-16 |
4 |
D |
$47.25 |
$58,307 |
D/D |
(1,234) |
304,382 |
|
- |
|
Stephenson Brian C |
See Remarks |
|
2021-11-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,488 |
305,616 |
|
- |
|
Stephenson Brian C |
See Remarks |
|
2021-08-16 |
4 |
D |
$49.48 |
$50,865 |
D/D |
(1,028) |
303,128 |
|
- |
|
Stephenson Brian C |
See Remarks |
|
2021-08-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,487 |
304,156 |
|
- |
|
Kumar Neil |
CEO and President |
|
2021-08-16 |
4 |
D |
$49.48 |
$184,560 |
D/D |
(3,730) |
4,719,011 |
|
- |
|
Kumar Neil |
CEO and President |
|
2021-08-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
7,523 |
4,722,741 |
|
- |
|
Scheller Richard H |
See Remarks |
|
2021-08-04 |
4 |
S |
$53.23 |
$733,317 |
D/D |
(13,777) |
45,860 |
|
28% |
|
Scheller Richard H |
See Remarks |
|
2021-08-04 |
4 |
OE |
$17.00 |
$234,209 |
D/D |
13,777 |
59,637 |
|
- |
|
Stephenson Brian C |
See Remarks |
|
2021-05-16 |
4 |
D |
$53.66 |
$46,255 |
D/D |
(862) |
301,669 |
|
- |
|
Stephenson Brian C |
See Remarks |
|
2021-05-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,488 |
302,531 |
|
- |
|
Kumar Neil |
CEO and President |
|
2021-05-16 |
4 |
D |
$53.66 |
$200,205 |
D/D |
(3,731) |
4,715,218 |
|
- |
|
Kumar Neil |
CEO and President |
|
2021-05-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
7,524 |
4,718,949 |
|
- |
|
Homcy Charles J |
Director |
|
2021-03-01 |
4 |
D |
$71.91 |
$37,681 |
D/D |
(524) |
1,204,764 |
|
- |
|
Homcy Charles J |
Director |
|
2021-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
1,521 |
1,205,288 |
|
- |
|
288 Records found
|
|
Page 5 of 12 |
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Acquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|